Newsroom

Genetic Technologies Announces Comprehensive Review of Strategic Alternatives

August 25, 2017

MELBOURNE, AUSTRALIA--(Marketwired - Aug 25, 2017) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company"), a molecular diagnostics company focused on cancer risk assessment, and provider of BREVAGenplus@, a fir...
Continue reading


Genetic Technologies Launches Breast Cancer Awareness Month Promotion for BREVAGenplus(R)

August 01, 2017

MELBOURNE, AUSTRALIA--(Marketwired - Aug 1, 2017) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company"), a molecular diagnostics company specialising in cancer genomics, and provider of BREVAGenplus@, a first...
Continue reading


Genetic Technologies Limited: Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 30 June 2017

July 27, 2017

MELBOURNE, AUSTRALIA--(Marketwired - Jul 27, 2017) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) HIGHLIGHTS Revised BREVAGenplus<...
Continue reading


Genetic Technologies Receives Nasdaq Deficiency Notice

July 21, 2017

MELBOURNE, AUSTRALIA--(Marketwired - Jul 21, 2017) - Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company"), today announced that on 20 July 2017, it received a notification letter (the "Notice") from the Listing Qualifications Departme...
Continue reading



View All Press Releases